References
Bertoletti A, Ferrari C: Kinetics of the immune response during HBV and HCV infection. Hepatology 38:4–13, 2003
Penna A, Del Prete G, Cavalli A, Bertoletti A, D'Elios MM, Sorrentino R, D'Amato M, Boni C, Pilli M, Fiaccadori F, Ferrari C: Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis. Hepatology 25:1022–1027, 1997
Rossol S, Marinos G, Carucci P, Singer MV, Williams R, Naumov NV: Interleukin 12 induction of TH1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest 99:3025–3033, 1997
Rico MA, Quiroga JA, Subira D, Castanon S, Esteban JM, Pardo M, Carreno V: Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha. Hepatology 33:295–300, 2001
Ben-Ari Z, Mor E, Papo O, Kfir B, Sulkes J, Tambur AR, Tur-Kaspa R, Klein T: Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 98:144–150, 2003
Zampino R, Marrone A, Cirillo G, Miraglia del Giudice E, Utili R, Karayiannis P, Liang TJ, Ruggiero G: Sequential analysis of HBV core promoter and precore regions in cancer survivor patients with chronic hepatitis B before, during and after interferon treatment. J Viral Hepat 9:183–188, 2002
Marrone A, Zampino R, Luongo G, Utili R, Karayiannis P, Ruggiero G: Low HBeAg serum levels correlate with the presence of the double A1762T/G1764A core promoter mutation and a positive response to interferon in patients with chronic hepatitis B virus infection. Intervirology 46:222–226, 2003
Erhardt A, Reineke U, Blondin D Gerlich WH, Adams O, Heintges T, Niederau C, Haussinger D: Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B. Hepatology 31:716–725, 2000
Milich DR, Jones JE, Hughes JL, Price J, Rnaey AK, McLachlan A: Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci USA 87:6599–6603, 1990
Boni C, Penna A, Ogg GS, Bertoletti A, Pilli M, Cavallo C, Cavalli A, Urbani S, Boehme R, Panebianco R, Fiaccadori F, Ferrari C: Lamivudine can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 33:963–971, 2001
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zampino, R., Mangoni, E.D., Marrone, A. et al. Interferon-Induced Anti-HBE Seroconversion Correlates with a Th1 Cytokine Shift Following Emergence of Core Promoter Mutations in Chronic Hepatitis B. Dig Dis Sci 50, 1791–1792 (2005). https://doi.org/10.1007/s10620-005-2939-4
Issue Date:
DOI: https://doi.org/10.1007/s10620-005-2939-4